Figure 1From: Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study Color slit-lamp photographs of a patient with conjunctival inflammation following subconjunctival injection of sirolimus. Significant chemosis along with conjunctival hyperemia overlying the whitish subconjunctival aggregate of the study drug can be seen.Back to article page